WO2023227997 - PHARMACEUTICAL COMPOSITION CONTAINING COMBINATION OF AZILSARTAN AND CHLORTHALIDONE AND PROCESS OF PREPARATION THEREOF
National phase entry is expected:
Publication Number
WO/2023/227997
Publication Date
30.11.2023
International Application No.
PCT/IB2023/054928
International Filing Date
12.05.2023
Title **
[English]
PHARMACEUTICAL COMPOSITION CONTAINING COMBINATION OF AZILSARTAN AND CHLORTHALIDONE AND PROCESS OF PREPARATION THEREOF
[French]
COMPOSITION PHARMACEUTIQUE CONTENANT UNE COMBINAISON D'AZILSARTAN ET DE CHLORTHALIDONE ET SON PROCÉDÉ DE PRÉPARATION
Applicants **
ALEMBIC PHARMACEUTICALS LIMITED
Inventors
REDDY, Konda Ramakrishna
SAHOO, Ashok kumar
SAHOO, Barada Prasanna
DABRE, Dr Rahul Sudhakar
Priority Data
202221029541
23.05.2022
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1958 | |
| EPO | Filing, Examination, Granting | 11551 | |
| Japan | Filing, Examination, Granting | 1907 | |
| South Korea | Filing, Examination, Granting | 1603 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,759
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present subject matter relates to a solid oral pharmaceutical composition comprising combination of azilsartan and chlorthalidone or a pharmaceutically acceptable salt thereof with at least one pharmaceutically acceptable excipient. The present subject matter also relates to a fixed dose pharmaceutical composition comprising azilsartan and chlorthalidone or a pharmaceutically acceptable salt thereof with at least one pharmaceutically acceptable excipient. Furthermore, it also relates to methods for manufacturing such compositions and use thereof.[French]
La présente invention concerne une composition pharmaceutique orale solide comprenant une combinaison d'azilsartan et de chlorthalidone ou d'un sel pharmaceutiquement acceptable de ceux-ci avec au moins un excipient pharmaceutiquement acceptable. La présente invention concerne également une composition pharmaceutique à dose fixe comprenant de l'azilsartan et de la chlorthalidone ou un sel pharmaceutiquement acceptable de ceux-ci avec au moins un excipient pharmaceutiquement acceptable. En outre, l'invention concerne également des procédés de fabrication de telles compositions et leur utilisation.